Table 3.
Liver volume measured by computed tomography (CTLV), liver weight and liver density in 49 patients according to aetiology of cirrhosis and Model for End-stage Liver Disease (MELD) score
| CTLV, ml, median (range) | Liver weight, g, median (range) | Liver density, kg/1, median (range) | |
|---|---|---|---|
| All patients (n = 49) | 1298 (530–3126) | 1300 (600–2500) | 0.92 (0.70–1.60) |
| Alcohol-related cirrhosis (n = 23) | 1273 (676–2158) | 1300 (600–2100) | 0.92 (0.72–1.62) |
| HCV infection (n = 18) | 1437 (730–2298) | 1425 (700–2000) | 0.92 (0.72–1.34) |
| HBV infection (n = 5) | 757 (530–1202)a | 830 (600–1950) | 1.11 (1.06–1.62)a |
| NASH (n = 5) | 1807 (797–3126) | 1600 (800–2500) | 0.88 (0.79–1.00) |
| Biliary diseases (n = 8) | 1628 (684–1963) | 1550 (600–1900) | 0.90 (0.79–0.97) |
| MELD score > 15 (n = 18) | 1198 (530–2146)a | 1100 (600–1950)a | 0.98 (0.72–1.16) |
a
P < 0.050, Mann–Whitney U-test.
HCV, hepatitis C virus; HBV, hepatitis B virus; NASH, non-alcoholic steatohepatitis.